Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for Preventing Neuropathic Pain Post-mastectomy
NCT01536314Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Feb 2012
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in neuropathic pain comparing Memantine with Placebo (2 arms). Primary endpoint: Average painful intensity at 3 months. Started Feb 2012; status: completed.
02
Drugs
memantine
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT01536314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01536314.